---
layout: post
title: "Bridging for Drug-Device and Biologic-Device Combination Products; Draft Guidance for Industry; Availability; Extension of Comment Period"
date: 2026-02-05 19:08:34 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-03023
original_published: 2020-02-14 00:00:00 +0000
significance: 8.00
---

# Bridging for Drug-Device and Biologic-Device Combination Products; Draft Guidance for Industry; Availability; Extension of Comment Period

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 14, 2020 00:00 UTC
**Document Number:** 2020-03023

## Summary

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of December 19, 2019. In the notice of availability, FDA requested comments on the draft guidance for industry entitled "Bridging for Drug-Device and Biologic-Device Combination Products." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/02/14/2020-03023/bridging-for-drug-device-and-biologic-device-combination-products-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2020-03023

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
